Sharing this page with your friends could help raise up to 3x more in donations
Diazepam (including Prodes brand) cannot be bought online through secure home access gateways as a Schedule IV controlled substance requiring a valid EPCS prescription from a DEA-registered US healthcare provider for anxiety, muscle spasms, or alcohol withdrawal; prescription-free online procurement violates 21 U.S.C. § 841 federal felony distribution laws with up to 20-year imprisonment penalties and $250,000 fines.
Prodes diazepam 5mg dosing mirrors US standards at 2-10mg BID-TID maximum 40mg/day divided under 2025 guidelines prioritizing shortest duration, with DEA telemedicine flexibilities expiring December 31, 2025 mandating synchronous HIPAA video HAM-A ≥18 or CIWA-Ar ≥10 confirmation plus multi-state PDMP clearance—no home gateway bypasses EPCS two-factor authentication or post-flex in-person exam requirements across 50 states.
Diazepam 5mg (GABA-A α1/α2/α5 agonist Ki 15nM), Tmax 1h, t½ 20-50h active nordiazepam metabolite; black box warnings cover 25-40% dependence by week 4, respiratory depression OR10 with opioids, anterograde amnesia 10-20%—taper 0.5-1mg weekly over 8-12 weeks CIWA-B monitoring; contraindications acute glaucoma, severe COPD AHI>30, myasthenia gravis.
Diagnostic: HAM-A ≥18 anxiety or CIWA-Ar ≥10 withdrawal + 6-month collateral excluding mimics.
Pre-Rx: PDMP zero fills 12mo, MoCA ≥25, negative UDS opioids/ethanol.
EPCS: #90 tabs 5mg ≤5 refills/6mo pharmacy-direct signature delivery.
Monitoring: ≥25% HAM-A/CIWA q30d + randomized UDS/pill counts.
| Incidence | Toxicity Domain | Risk Factors | Management |
|---|---|---|---|
| 25-45% | Sedation RASS -2/-4, ataxia | Elderly >10mg CYP2C19 PM | Morning dose fall alarms |
| 15-30% | Tolerance HAM-A rebound | >6 weeks continuous | SSRI transition buspirone |
| 10-25% | Respiratory RR<12 SaO2<90% | Opioid/ethanol | Naloxone 4mg IN standby |
| 5-15% | Disinhibition/agitation | SUD history | Haloperidol 2-5mg switch |
| 1-5% | Withdrawal seizures | Abrupt >4 weeks | Phenobarbital rescue taper |
Interactions: CYP3A4i x2-3 AUC, opioids OR10 respiratory, ethanol x5 GABA potentiation.
PDMP AI 95% sensitivity flags diversion (cash >$150/mo, >3 pharmacies/30d); 45 states PDMP pre-Rx, 32 states ≤30-day initial, 18 states specialist >20mg/day; DEA monitors 22% benzo scripts diverted via unaccredited online platforms.
| Tier | Intervention | HAM-A Responder (12 Weeks) | Onset | Dependence |
|---|---|---|---|---|
| CBT Base | 12 sessions | 60-70% | 6-8 weeks | None |
| SSRI Primary | Sertraline 50-200mg | 55-65% | 4-6 weeks | <1% |
| Hydroxyzine PRN | 25-100mg TID | 45% acute | 30min | Negligible |
| Diazepam Bridge | 2-10mg TID max 4 weeks | 70-80% rapid | 15-60min | High 25-40% |
Secure home access gateway legal absent EPCS? Negative—Ryan Haight felony 20 years per transaction.
Telemedicine flex expiration? 12/31/2025 in-person mandatory.
Max hospitalized daily dose? 40mg divided.
Opioid respiratory OR? OR10 FDA data.